Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction (Q35679203)
Jump to navigation
Jump to search
scientific article published on 11 December 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction |
scientific article published on 11 December 2014 |
Statements
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction (English)
M Mensah
11 December 2014
1 December 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference